Overall rank by patents
#13,499
of 50,000 tracked assignees
USPTO PatentsView assignee record - 22 granted patents across 6 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).
The verdict
According to USPTO PatentsView, Inventisbio ranks #13,499 of 50,000 tracked US assignees by granted-patent volume, with 22 patents across 6 technology areas.
USPTO PatentsView assignee plate
Corpus R13499 · Foreign Corporation #13,499 · 22 grants
GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
Nearest grant-volume peer: Imasen Electric Industrial Co., Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Inventisbio · this assignee
46 score
3D Lighting Innovati… · lowest
7 score
What this shows Inventisbio Co., Ltd. stamps GRANTS-SMALL, MID-PACK, PHOTO-FINISH, CPC-NARROW, INNOV-PAR, CLAIMS-RICH, TYPE-FRNCORP, SPAN-YRS, BOOK-RICH. Volume places it #13,499 of 50,000; Innovation Score 45.6/100 sits in the top 23% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Imasen Electric Industrial Co., Ltd. (±0 grants).
Inventisbio Co., Ltd. has been granted 22 US utility patents between 2020 and 2025, placing Inventisbio Co., Ltd. at #13,499 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 6 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.9 claims per patent with primary concentration in A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). As a Foreign Corporation, Inventisbio Co., Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, Inventisbio sits between Importla, Llc (22 patents, rank #13,478) and Impressions Vanity Company (22 patents, rank #13,486) - the closest US assignees by grant volume. The composite Innovation Score of 45.6/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Historical data spans 2020 through 2025, with 22 total grants over that period. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The Foreign Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. Inventisbio Co., Ltd.'s 16.9 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 6 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
IMPORTLA, LLC
22 patents
INFINITESIMA LIMITED
22 patents
INTERNATIONAL CURRENCY TECHNOLOGIES CORPORATION
22 patents
INTHESMART Co., Ltd.
22 patents
INZICONTROLS CO., LTD
22 patents
ISHIDA EUROPE LIMITED
22 patents
Imasen Electric Industrial Co., Ltd.
22 patents
Impressions Vanity Company
22 patents
INVENTISBIO CO., LTD.
22 patents
What this shows Inventisbio holds 22 patents at rank #13,482, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #13,482 in granted patent volume.
Other assignees with the most granted patents in Inventisbio's primary technology class.
Inventisbio's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
46 Top 23% higher than 77% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 1 | 4.5% |
| 2021 | 4 | 18.2% |
| 2022 | 4 | 18.2% |
| 2023 | 3 | 13.6% |
| 2024 | 5 | 22.7% |
| 2025partial year | 5 | 22.7% |
Top 6 of 6 technology areas
Overall rank by patents
#13,499
of 50,000 tracked assignees
45.6 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.